AzTrials
AzTrials

Carotid StenosisNCT04255316

Modified Method of Eversion Carotid Endarterectomy in Patients With Extensive Atherosclerotic Disease of Carotid Bifurcation

A study testing Modified method of eversion carotid endarterectomy and Standard method of eversion carotid endarterectomy in people with Carotid Stenosis and Carotid Artery Diseases, run by Pirogov Russian National Research Medical University at 1 site in Russia.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

A prospective comparative randomized single-centre non-inferiority trial. The purpose of this study is to compares of modified method of eversion carotid endarterectomy with standard eversion carotid endarterectomy for 3,6 and 12 months days after operation in patients with extensive atherosclerotic disease of carotid… Read more about this study

Who is it for?
Ages 18 to 85 years
Conditions the study is for
Carotid Stenosis, Carotid Artery Diseases
What is being tested?
Modified method of eversion carotid endarterectomy and Standard method of eversion carotid endarterectomy
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
126 participants
Where
1 siteRussia
Study dates
1 Oct 2017to 1 Mar 2020
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 85 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • patients with stenosis of ICA 70-99% (ultrasound - NASCET and CT angiography)
  • patients with a extensive lesion of the ICA (plaque < 2 cm) by ultrasound - NASCET and CT angiography

Who cannot join

  • patients with a extensive lesion of the ICA (plaque < 2 cm),
  • patients with a contralateral occlusion of the ICA
  • patients with stroke in ischemic type in the acute period.

Trial locations and contacts

1 site in 1 country.

Russia1 site
  • The Federal Budget-Funded Institution National Medical Surgical Center named after N. I. Pirogov of the Ministry of health of the Russian Federation

    Moscow, 117997

Other trials in Russia

About this study

A prospective comparative randomized single-centre non-inferiority trial. The purpose of this study is to compares of modified method of eversion carotid endarterectomy with standard eversion carotid endarterectomy for 3,6 and 12 months days after operation in patients with extensive atherosclerotic disease of carotid bifurcation

Read the detailed description

Introduction. Performing eversion endarterectomy some difficulties arise. Firstly, it requires a great deal of coherence between the work of the surgeon and the first assistant, as well as a great experience of the latter. Secondly, in some cases, there are difficulties in visualizing the distal margin of the intima: in the absence of a rigid skeleton, the soft unchanged artery walls after removal of the plaque subside, making it difficult to visualize possible fragments of the intima. Thirdly, the cost of the error is high: with a random de-version, repeated eversion turns out to be impossible. It should be noted that the use of an eversion technique becomes difficult to implement, and sometimes impossible, with extended stenosis, since a very high allocation of the ICA is required, which increases the invasiveness of the operation and the difficulty of access. With prolonged stenosis, the carotid endarterectomy remains the option of choice. The modification used eversion carotid endarterectomy combines the advantages of both methods, and also eliminates the limitations of the carotid endarterectomy and eversion carotid endarterectomy.

The aim of study. The purpose of this study is to compares of modified method of eversion carotid endarterectomy with standard eversion carotid endarterectomy for 3,6 and 12 months days after operation in patients with extensive atherosclerotic disease of carotid bifurcation

Being tested
Modified method of eversion carotid endarterectomy, Standard method of eversion carotid endarterectomy
Keywords
carotid endarterectomy, eversion carotid endarterectomy, prophylaxis of ischemic stroke, carotid arteriosclerosis, carotid artery plasty
Medical subject headings
Carotid Stenosis, Carotid Artery Diseases

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Modified method of eversion carotid endarterectomyProcedure or surgery

    Mini approach for CCA bifurcation - Clamping ICA, ECA and CCA - ICA is cut off with a scalpel at the mouth itself - Dissection of the ICA and ECA in the distal direction to the distal border of the atherosclerotic plaque - Endarterectomy - Performing of a new bifurcation of the CCA with prolene 7/0

  • Standard method of eversion carotid endarterectomyProcedure or surgery

    standard eversion technic

Study groups in NCT04255316
Study groupRoleWhat they receive
Modified eversionExperimentalPatients with extensive atherosclerotic lesion of the carotid bifurcation (more 25mm in internal carotid artery) undergo a modified eversion carotid endarterectomy
Receives: Procedure: Modified method of eversion carotid endarterectomy
Standard eversionActive comparatorPatients with extensive atherosclerotic lesion of the carotid bifurcation (more 25mm in internal carotid artery) undergo a standard eversion carotid endarterectomy
Receives: Procedure: Standard method of eversion carotid endarterectomy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Assessment of total stroke rate

    assessment of the total stroke rate in patients undergoing intervention after 30 days

    Measured: 30 days

  2. Assessment of mortality rate

    assessment of the mortality rate in patients undergoing intervention after 30 days

    Measured: 30 days

Secondary outcomes (2)
  1. Assessment of stroke frequency

    assessment of stroke frequency in patients undergoing intervention after 12 months

    Measured: 12 months

  2. Assessment of the incidence of internal carotid artery restenosis

    Assessment of the incidence of internal carotid artery restenosis after 3, 6 and 12 months

    Measured: 3, 6, 12 months

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Feb 2020
  2. Study start1 Oct 2017
  3. Primary completion28 Feb 2020
  4. Study completion1 Mar 2020

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
126 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04255316
Sponsor's protocol ID
23
Status last verified
Jan 2020
First submitted
27 Jan 2020
Last updated
15 Jan 2021
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Modified method of eversion carotid endarterectomy and Standard method of eversion carotid endarterectomy in people with Carotid Stenosis and Carotid Artery Diseases, run by Pirogov Russian National Research Medical University at 1 site in Russia.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 15 Jan 2021. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Russia. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Assessment of total stroke rate (time frame: 30 days). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 15 Jan 2021.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in